How long does the effect of brigatinib last?

The duration of efficacy of brigatinib is a complex issue because it is affected by multiple factors, including the half-life of the drug, individual differences among patients, and the specific conditions of the disease. Below I will elaborate on the duration of efficacy of brigatinib from several aspects.

First of all, from the perspective of the half-life of the drug, brigatinib has a relatively long half-life. Based on publicly available information, the half-life of brigatinib is approximately 25 hours. This means it takes longer for the drug's concentration in the body to reduce to half, allowing the drug's effects to last longer. This pharmacokinetic profile makes brigatinib a drug suitable for once-daily oral administration, making it easier for patients to take the drug.

Secondly, the duration of efficacy of brigatinib is also affected by individual differences among patients. Everyone's physical condition, genetic variation, and drug metabolism ability are different, and these factors will affect the duration of the drug's effect. For example, some patients may see significant improvement within a few weeks of taking brigatinib, while others may take several months to see significant improvement. Therefore, the specific duration of drug effect needs to be evaluated based on the actual situation of the patient.

In addition, the specific condition of the disease will also affect the duration of brigatinib's efficacy. Non-small cell lung cancer is a complex disease that varies in speed and severity from person to person. At different stages of the disease, patients respond differently to medications. Therefore, the duration of efficacy of brigatinib may fluctuate as the condition changes.

References:

https://go.drugbank.com/drugs/DB12267